N-terminal protype-B natriuretic peptide and Doppler diastolic variables are incremental for risk stratification of patients with NYHA class I-II systolic heart failure

International Journal of Cardiology

Volumn 136, Issue 2, 2009, Pages 144-150

  Dini, Frank Lloyd ^a   Fontanive, Paolo ^a   Buralli, Simona ^b   Panicucci, Erica ^b   Andreini, Diana ^a   Conti, Umberto ^a   De Tommasi, Salvatore Mario ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Diastolic dysfunction; Echocardiography; Heart failure; Natriuretic peptides

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; DIASTOLE; DIASTOLIC DYSFUNCTION; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTOLIC HEART FAILURE; TISSUE DOPPLER IMAGING; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

AGED; AGED, 80 AND OVER; DIASTOLE; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, SYSTOLIC; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MITRAL VALVE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SYSTOLE;

EID: 67650941582     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.04.032     Document Type: Article

References (38)

1. Hunt S.A. American College of Cardiology; American heart Association Task Force on Practice Guidelines: ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 46 (2005) 1-82
2. Stevenson L.W., and Perloff J.K. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 261 (1989) 84-88
3. Chakko S., Woska D., Martinez H., et al. Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care. Am J Med 90 (1991) 353-359
4. Ammar K., Jacobsen S.J., Mahoney D.W., et al. Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community. Circulation 115 (2007) 1563-1570
5. Dokainish H., Zoghbi W.A., Lakkis N.M., et al. Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure. J Am Coll Cardiol 45 (2004) 1223-1226
6. Bruch C., Rothenburger M., Gotzmann M., et al. Risk stratification in chronic heart failure: independent and incremental prognostic value of echocardiography and brain natriuretic peptide and its N-terminal fragment. J Am Soc Echocardiogr 19 (2006) 522-528
7. Lim T.K., Hayat S.A., Gaze D., Celik E., Collison P., and Senior R. Independent value of echocardiography and N-terminal pro-natriuretic peptide for the prediction of major outcomes in patients with suspected heart failure. Am J Cardiol 100 (2007) 870-875
8. Lang R.M., Bierig M., and Deveraux R.B. Recommendations for chamber quantification. Eur J Echocardiogr 7 (2006) 79-108
9. Helmcke F., Nanda N.C., Hsiung M.C., et al. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation 75 (1987) 175-183
10. Hall S., Brickner M., Willet D., et al. Assessment of mitral regurgitation by Doppler color flow mapping of the vena contracta. Circulation 95 (1997) 636-642
11. Nishimura R.A., and Tajik A.J. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is clinician's Rosetta stone. J Am Coll Cardiol 30 (1997) 8-18
12. Ommen S.R., Nishimura R.A., Appleton C.P., et al. Clinical utility of Doppler echocardiographic and tissue Doppler in the estimation of left ventricular filling pressures. Circulation 102 (2000) 1788-1794
13. McAlister F.A., Teo K.K., Taher M., et al. Insights into contemporary epidemiology and outpatient management of congestive heart failure. Am Heart J 138 (1999) 87-94
14. Muntwyler J., Abetel G., Gruner C., and Follath F. One-year mortality among unselected outpatients with heart failure. Eur Heart J 23 (2002) 1804-1806
15. Francis G.S., Benedict C., Johnstone D.E., et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with or without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 82 (1990) 1724-1729
16. Stevenson L.W., Tillisch J.H., Hamilton M., et al. Importance of hemodynamic response to therapy in predicting survival with ejection fraction < 20% secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol 66 (1990) 1348-1354
17. Johnson W., Omland T., Hall C., et al. Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure. J Am Coll Cardiol 39 (2002) 1623-1629
18. Nohria A., Tsang S.W., Fang J.C., et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol 41 (2003) 1797-1804
19. Parthenakis F.I., Kanoupakis E.M., Kochiadakis G.E., et al. Left ventricular diastolic filling pattern predicts cardiopulmonary determinants of functional capacity in patients with congestive heart failure. Am Heart J 140 (2000) 338-344
20. Tsutamoto T., Wada A., Maeda K., et al. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1. Eur Heart J 20 (1999) 1799-1807
21. Gardner R.S., Ozalp E., Murday A.J., Robb S.D., and McDonagh T.A. N-terminal pro-brain natriuretic peptide. A gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 24 (2003) 1735-1743
22. Bayes-Genis A., Pascual-Figal D., Fabregat J., et al. Serial NT-proBNP monitoring and outcomes in outpatients with decompensation of heart failure. Int J Cardiol 120 (2007) 338-343
23. Bettencourt P., Azevedo A., Fonseca L., et al. Prognosis of decompensated heart failure patients with preserved systolic function is predicted by NT-proBNP variations during hospitalization. Int J Cardiol 117 (2007) 75-79
24. Werner G.S., Shafer C., Dirks R., Figulla H.R., and Kreuzer H. Prognostic value of Doppler echocardiographic assessment of left ventricular filling in dilated cardiomyopathy. Am J Cardiol 73 (1994) 792-798
25. Xie G.Y., Berk M.R., Smith M.D., et al. Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure. J Am Coll Cardiol 24 (1994) 132-139
26. Pozzoli M., Traversi E., Cioffi G., Stenner R., Sanarico M., and Tavazzi L. Loading manipulations improve the prognostic value of Doppler evaluation of mitral flow in patients with chronic heart failure. Circulation 95 (1997) 1222-1230
27. Wang M., Yip G.W., Wang A.Y., et al. Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value. J Am Coll Cardiol 41 (2003) 820-826
28. Hillis G.S., Moller J.E., Pellikka P., et al. Non invasive estimation of left ventricular filling pressure by E/E′ is a powerful predictor of survival after acute myocardial infarction. J Am Coll Cardiol 43 (2004) 360-367
29. Acil T., Wichter T., Stypmann J., et al. Prognostic value of tissue Doppler imaging in patients with chronic congestive heart failure. Int J Cardiol 103 (2005) 175-181
30. Traversi E., Pozzoli M., Cioffi G., et al. Mitral flow velocity changes after 6 months of optimized therapy provide important hemodynamic and prognostic information in patients with chronic heart failure. Am Heart J 132 (1996) 809-819
31. Pinamonti B., Zecchin M., Di Lenarda A., Gregori D., Sinagra G., and Camerini F. Persistence of restrictive left ventricular filling pattern in dilated cardiomyopathy: an ominous sign. J Am Coll Cardiol 29 (1997) 604-612
32. Temporelli P.L., Corrà U., Imparato A., Bosimini E., Scapellato F., and Giannuzzi P. Reversible restrictive left ventricular diastolic filling with optimized oral therapy predicts more favorable prognosis in patients with chronic heart failure. J Am Coll Cardiol 31 (1998) 1591-1597
33. Jourdain P., Joundeau G., Funck F., et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure. J Am Coll Cardiol 49 (2007) 1733-1739
34. Sato Y., Kuwabara Y., Taniguchi R., et al. Malignant link between chronic heart failure and acute cardiac decompensation in patients with persistently increased serum concentrations of cardiac troponin. Int J Cardiol 126 (2008) 171-176
35. Costello-Boerrigter L.C., Boerrigter G., Redfield M.M., et al. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. J Am Coll Cardiol 47 (2006) 345-353
36. Luchner A., Hengstenberg C., Lowel H., Riegger G.A.J., Schunkert H., and Holmer S. Effect of compensated renal dysfunction on approved heart failure markers. Direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP. Hypertension 46 (2005) 118-123
37. Goei D., Schouten O., Boersma E., et al. Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery. Am J Cardiol 101 (2008) 122-126
38. Bruch C., Reinecke H., Stypmann J., et al. N-terminal pro-brain natriuretic peptide, kidney disease and outcome in patients with chronic heart disease. J Heart Lung Transplant 25 (2006) 1135-1141